Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Early Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (50.0%)Not Applicable
1 (50.0%)Microbiome Shift in Peri-mucositis by Anti-inflammatory Drugs
Early Phase 1
- Conditions
- Peri-implant Mucositis
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-03-24
- Last Posted Date
- 2017-03-31
- Lead Sponsor
- Polak David
- Target Recruit Count
- 100
- Registration Number
- NCT03090009
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Polymorphonuclear Cells' Sensitivity to Aggregatibacter Actinomycetemcomitans Bacteria in Patients With Aggressive Periodontitis
Not Applicable
- Conditions
- Periodontal Disease
- First Posted Date
- 2013-12-12
- Last Posted Date
- 2013-12-16
- Lead Sponsor
- Polak David
- Target Recruit Count
- 75
- Registration Number
- NCT02010307
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel, Jerusalem, Israel
News
No news found